Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
  2. Cheng, Cheng; Duan, Hongying; Xu, Kai; Chuang, Gwo-Yu; Corrigan, Angela R; Geng, Hui; O'Dell, Sijy; Ou, Li; Chambers, Michael; Changela, Anita; Chen, Xuejun; Foulds, Kathryn E; Sarfo, Edward K; Jafari, Alexander J; Hill, Kurt R; Kong, Rui; Liu, Kevin; Todd, John P; Tsybovsky,Yaroslav; Verardi, Raffaello; Wang, Shuishu; Wang, Yiran; Wu, Winston; Zhou, Tongqing; Arnold, Frank J; Doria-Rose, Nicole A; Koup, Richard A; McDermott, Adrian B; Scorpio, Diana G; Worobey, Michael; Shapiro, Lawrence; Mascola, John R; Kwong, Peter D
  3. Cell reports. 2020, Aug 04; 32(5): 107981.
  1. 2.   Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
  2. Ueda, George; Antanasijevic, Aleksandar; Fallas, Jorge A; Sheffler, William; Copps, Jeffrey; Ellis, Daniel; Hutchinson, Geoffrey B; Moyer, Adam; Yasmeen, Anila; Tsybovsky,Yaroslav; Park, Young-Jun; Bick, Matthew J; Sankaran, Banumathi; Gillespie, Rebecca A; Brouwer, Philip Jm; Zwart, Peter H; Veesler, David; Kanekiyo, Masaru; Graham, Barney S; Sanders, Rogier W; Moore, John P; Klasse, Per Johan; Ward, Andrew B; King, Neil P; Baker, David
  3. eLife. 2020, Aug 04; 9: pii: 9:e57659.
  1. 3.   Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development
  2. Yuan, T. T.; Li, J. J.; Zhang, Y.; Wang, Y. P.; Streaker, E.; Dimitrov, D. S.; Zhang, M. Y.
  3. Vaccine. 2011, Sep; 29(40): 6903-6910.
  1. 4.   Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
  2. Burton, D. R.; Hessell, A. J.; Keele, B. F.; Klasse, P. J.; Ketas, T. A.; Moldt, B.; Dunlop, D. C.; Poignard, P.; Doyle, L. A.; Cavacini, L.; Veazey, R. S.; Moore, J. P.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(27): 11181-11186.
  1. 5.   Conformational and Structural Features of HIV-1 gp120 Underlying the Dual Receptor Antagonism by Cross-Reactive Neutralizing Antibody m18
  2. Gift, S. K.; Zentner, I. J.; Schon, A.; McFadden, K.; Umashankara, M.; Rajagopal, S.; Contarino, M.; Duffy, C.; Courter, J. R.; Zhang, M. Y.; Gershoni, J. M.; Cocklin, S.; Dimitrov, D. S.; Smith, A. B.; Freire, E.; Chaiken, I. M.
  3. Biochemistry. 2011, Apr; 50(14): 2756-2768.
  1. 6.   Structural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41
  2. Gustchina, E.; Li, M.; Louis, J. M.; Anderson, D. E.; Lloyd, J.; Frisch, C.; Bewley, C. A.; Gustchina, A.; Wlodawer, A.; Clore, G. M.
  3. Plos Pathogens. 2010, Nov; 6(11): 19.
  1. 7.   Potent and broad neutralizing activity of a single chain antibody fragment against cell-free and cell-associated HIV-1
  2. Zhang, M. Y.; Borges, A. R.; Ptak, R. G.; Wang, Y. P.; Dimitrov, A. S.; Alam, S. M.; Wieczorek, L.; Bouma, P.; Fouts, T.; Jiang, S. B.; Polonis, V. R.; Haynes, B. F.; Quinnan, G. V.; Montefiori, D. C.; Dimitrov, D. S.
  3. Mabs. 2010, May-Jun; 2(3): 266-274.
  1. 8.   Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
  2. Xiao, X. D.; Chen, W. Z.; Feng, Y.; Dimitrov, D. S.
  3. Viruses-Basel. 2009, Dec; 1(3): 802-817.
  1. 9.   Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
  2. Chen, L.; Kwon, Y. D.; Zhou, T. Q.; Wu, X. L.; O'Dell, S.; Cavacini, L.; Hessell, A. J.; Pancera, M.; Tang, M.; Xu, L.; Yang, Z. Y.; Zhang, M. Y.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Nabel, G. J.; Posner, M. R.; Sodroski, J.; Wyatt, R.
  3. Science. 2009 326(5956): 1123-1127.
  1. 10.   Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen
  2. Zhang, M. Y.; Wang, Y. P.; Mankowski, M. K.; Ptak, R. G.; Dimitrov, D. S.
  3. Vaccine. 2009 27(6): 857-863.
  1. 11.   Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion
  2. Dimitrov, A. S.; Jacobs, A.; Finnegan, C. M.; Stiegler, G.; Katinger, H.; Blumenthal, R.
  3. Biochemistry. 2007, Feb; 46(5): 1398-1401.
  1. 12.   Structural definition of a conserved neutralization epitope on HIV-1 gp120
  2. Zhou, T. Q.; Xu, L.; Dey, B.; Hessell, A. J.; Van Ryk, D.; Xiang, S. H.; Yang, X. Z.; Zhang, M. Y.; Zwick, M. B.; Arthos, J.; Burton, D. R.; Dimitrov, D. S.; Sodroski, J.; Wyatt, R.; Nabel, G. J.; Kwong, P. D.
  3. Nature. 2007, Feb; 445(7129): 732-737.
  1. 13.   Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning
  2. Zhang, M. Y.; Choudhry, V.; Sidorov, I. A.; Tenev, V.; Vu, B. K.; Choudhary, A.; Lu, H.; Stiegler, G. M.; Katinger, H. W. D.; Jiang, S.; Broder, C. C.; Dimitrov, D. S.
  3. Journal of Immunological Methods. 2006, Dec; 317(1-2): 21-30.
  1. 14.   Antibody-based inhibitors of HIV infection
  2. Choudhry, V.; Zhang, M. Y.; Dimitrova, D.; Prabakaran, P.; Dimitrov, A. S.; Fouts, T. R.; Dimitrov, D. S.
  3. Expert Opinion on Biological Therapy. 2006, MAY; 6(5): 523-531.
  1. 15.   Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs
  2. Prabakaran, P.; Gan, J. H.; Wu, Y. Q.; Zhang, M. Y.; Dimitrov, D. S.; Ji, X. H.
  3. Journal of Molecular Biology. 2006, MAR 17; 357(1): 82-99.
  1. 16.   Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope
  2. Raviv, Y.; Viard, M.; Bess, J. W.; Chertova, E.; Blumenthal, R.
  3. Journal of Virology. 2005, OCT; 79(19): 12394-12400.
  1. 17.   Proteins that bind high-mannose sugars of the HIV envelope
  2. Botos, I.; Wlodawer, A.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 233-282.
  1. 18.   Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles
  2. Willey, R. L.; Byrum, R.; Piatak, M.; Kim, Y. B.; Cho, M. W.; Rossio, J. L.; Bess, J.; Igarashi, T.; Endo, Y.; Arthur, L. O.; Lifson, J. D.; Martin, M. A.
  3. Journal of Virology. 2003 77(2): 1163-1174.
  1. 19.   Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
  2. Labrijn, A. F.; Poignard, P.; Raja, A.; Zwick, M. B.; Delgado, K.; Franti, M.; Binley, J.; Vivona, V.; Grundner, C.; Huang, C. C.; Venturi, M.; Petropoulos, C. J.; Wrin, T.; Dimitrov, D. S.; Robinson, J.; Kwong, P. D.; Wyatt, R. T.; Sodroski, J.; Burton, D. R.
  3. Journal of Virology. 2003 77(19): 10557-10565.
  1. 20.   Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1
  2. Bouma, P.; Leavitt, M.; Zhang, P. F.; Sidorov, I. A.; Dimitrov, D. S.; Quinnan, G. V.
  3. Journal of Virology. 2003 77(14): 8061-8071.
  1. 21.   A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge
  2. Patterson, L. J.; Robey, F.; Muck, A.; Van Remoortere, K.; Aldrich, K.; Richardson, E.; Alvord, W. G.; Markham, P. D.; Cranage, M.; Robert-Guroff, M.
  3. Aids Research and Human Retroviruses. 2001 17(9): 837-849.
  1. 22.   Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120
  2. Esser, M. T.; Mori, T.; Mondor, I.; Sattentau, Q. J.; Dey, B.; Berger, E. A.; Boyd, M. R.; Lifson, J. D.
  3. Journal of Virology. 1999 73(5): 4360-4371.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel